Nisa Investment Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22K | Sell |
504
-51
| -9% | -$2.23K | ﹤0.01% | 1890 |
|
2025
Q1 | $15.2K | Sell |
555
-30
| -5% | -$821 | ﹤0.01% | 1992 |
|
2024
Q4 | $23.5K | Buy |
585
+51
| +10% | +$2.05K | ﹤0.01% | 1887 |
|
2024
Q3 | $25.3K | Buy |
534
+60
| +13% | +$2.84K | ﹤0.01% | 1831 |
|
2024
Q2 | $14.1K | Buy |
474
+23
| +5% | +$687 | ﹤0.01% | 2055 |
|
2024
Q1 | $18.1K | Buy |
451
+61
| +16% | +$2.45K | ﹤0.01% | 1928 |
|
2023
Q4 | $9.93K | Sell |
390
-1,315
| -77% | -$33.5K | ﹤0.01% | 2043 |
|
2023
Q3 | $23.7K | Buy |
1,705
+6
| +0.4% | +$83 | ﹤0.01% | 1965 |
|
2023
Q2 | $39.1K | Hold |
1,699
| – | – | ﹤0.01% | 1833 |
|
2023
Q1 | $50K | Sell |
1,699
-370
| -18% | -$10.9K | ﹤0.01% | 1717 |
|
2022
Q4 | $52K | Hold |
2,069
| – | – | ﹤0.01% | 1755 |
|
2022
Q3 | $63K | Sell |
2,069
-68
| -3% | -$2.07K | ﹤0.01% | 1657 |
|
2022
Q2 | $42K | Buy |
2,137
+1,650
| +339% | +$32.4K | ﹤0.01% | 1791 |
|
2022
Q1 | $21K | Sell |
487
-740
| -60% | -$31.9K | ﹤0.01% | 2039 |
|
2021
Q4 | $52K | Buy |
1,227
+447
| +57% | +$18.9K | ﹤0.01% | 1720 |
|
2021
Q3 | $46 | Sell |
780
-1,318
| -63% | -$78 | ﹤0.01% | 1954 |
|
2021
Q2 | $102 | Hold |
2,098
| – | – | ﹤0.01% | 1683 |
|
2021
Q1 | $82 | Hold |
2,098
| – | – | ﹤0.01% | 1833 |
|
2020
Q4 | $130K | Buy |
+2,098
| New | +$130K | ﹤0.01% | 1634 |
|